San Diego's Illumina cuts 5% of global workforce amid economic headwinds
Gene sequencing giant expects tough market conditions to linger into 2023 as cautious customers battle inflation.
Wednesday, November 16, 2022 at 6:18 am
Gene sequencing giant expects tough market conditions to linger into 2023 as cautious customers battle inflation.
Wednesday, November 16, 2022 at 6:18 am